Refine by
Applications
- Duodenal Mucosal Resurfacing System (DMR) for Type 2 Diabetes
- Duodenal Mucosal Resurfacing System (DMR) for Clinical Research Studies
- Duodenal Mucosal Resurfacing System (DMR) for T2Di Study
- Duodenal Mucosal Resurfacing System (DMR) for Healthcare Professionals
- Blood Glucose Meter and Diabetes Supply Products for Diabetes Education
- Blood Glucose Meter and Diabetes Supply Products for Diabetes Education - Exercise and Diabetes
- Blood Glucose Meter and Diabetes Supply Products for Diabetes Education - Exercise Safely
- Blood Glucose Meter and Diabetes Supply Products for Diabetes Education - Meal Planning
Insulin Therapy Equipment & Supplies
9 equipment items found
by:Zucara Therapeutics Inc. based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that impairs the glucagon response to hypoglycemia in people with insulin dependent diabetes. ZT-01 restores ...
Manufactured by:Fractyl Health based inLexington, MASSACHUSETTS (USA)
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to control HbA1c today is insulin dose escalation and lifestyle interventions. We have developed and are ...
Manufactured by:Admetsys Corporation based inBoston, MASSACHUSETTS (USA)
Autonomously regulates patient glucose with zero clinician intervention, directly infusing continuously-optimized insulin and dextrose ...
Manufactured by:Prodigy Diabetes Care, LLC based inCharlotte, NORTH CAROLINA (USA)
The Prodigy Count-a-dose is a simple way to fill insulin syringes safely and accurately with one or two bottles of insulin (any brand). The bottle holder is marked to identify bottles for easy mixing-one raised dot for the first bottle and two raised dots for the second bottle. With the click dial starting all the way down toward the raised minus (-) sign, the user simply moves the click dial the ...
Manufactured by:Betalin Therapeutics Ltd. based inJerusalem, ISRAEL
Islet transplantation is a widely used cell therapy technique which achieves normoglycemia (normal blood glucose levels) in diabetic patients. However, one of the biggest challenges is early islet cell death, this tends to occur before the transplantation procedure. This is thought to be due to the loss of the islets microenvironment during isolation. The extracellular matrix (ECM, a support ...
Manufactured by:Ypsomed AG based inBurgdorf, SWITZERLAND
With the mylife Loop Program1, Ypsomed plan to offer a modular insulin pump system that makes diabetes therapy a smaller thing in your life. Whether using Dexcom G6 Continuous Glucose Monitoring (CGM) System data and fully automated insulin delivery support or just a pump on its own without sensor data, you can control your ...
by:Accelerated Biosciences Corp. based inCarlsbad, CALIFORNIA (USA)
Stem cells possess two defining characteristics that give potential to address unmet medical needs in healthcare: 1) the ability to self-replicate throughout the life of an organism and 2) the ability to differentiate to many different cell types in the human ...
Manufactured by:ORGENTEC Diagnostika GmbH is part of the Sebia Group based inMainz, GERMANY
Anti-Insulin is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against animal (beef, pork) and human insulin in human serum or plasma. Anti-Insulin is an ELISA test for the quantitative determination of IgG antibodies against human, bovine and pig insulin in human serum or plasma. Type I diabetes mellitus is an autoimmune disease triggered by ...
Manufactured by:DxGen Corp. based inGunpo-si, SOUTH KOREA
Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. ...